IRulya Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IRLA and other ETFs, options, and stocks.

About IRLA

IRulya Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular Drug Encapsulation (AIDE) technology platform, which is a novel device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells. 

CEO
Brigette Michelle Roberts
CEOBrigette Michelle Roberts
Employees
38
Employees38
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2012
Founded2012
Employees
38
Employees38

IRLA Key Statistics

Market cap
429.70M
Market cap429.70M
Price-Earnings ratio
-0.51
Price-Earnings ratio-0.51
Dividend yield
—
Dividend yield—
Average volume
143.18K
Average volume143.18K
High today
$42.00
High today$42.00
Low today
$38.92
Low today$38.92
Open price
$39.94
Open price$39.94
Volume
198.68K
Volume198.68K
52 Week high
$909.98
52 Week high$909.98
52 Week low
$4.99
52 Week low$4.99

Stock Snapshot

IRulya Therapeutics(IRLA) stock is priced at $39.88, giving the company a market capitalization of 429.7M. It carries a P/E multiple of -0.51.

During the trading session on 2026-11-22, IRulya Therapeutics(IRLA) shares reached a daily high of $42.00 and a low of $38.92. At a current price of $39.88, the stock is +2.5% higher than the low and still -5.0% under the high.

Trading activity shows a volume of 198.68K, compared to an average daily volume of 143.18K.

The stock's 52-week range extends from a low of $4.99 to a high of $909.98.

The stock's 52-week range extends from a low of $4.99 to a high of $909.98.

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own IRLA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.